SLC38A5 and diabetic retinopathy: To evaluate the role of Slc38a5 in pathological retinal angiogenesis, we used a well-established OIR model (Smith et al., 1994), mimicking the hypoxia-induced proliferative phase as seen in retinopathy of prematurity and diabetic retinopathy.